Mohan Anand Chandavarkar

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 5 EPO patents. Top assignees: Council of Scientific and Industrial Research, Fdc Limited, Other. Active years: 2007-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohan Anand Chandavarkar. Retrieved from https://idiyas.com/inventor/mohan-anand-chandavarkar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 50.0

CIPO Patents = 4

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 6.8

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Bandra, IN (2007)
Mumbai, IN (2012 - 2017)

Company Filing History:

6 out of 2,130

Council of Scientific and Industrial Research

1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2007-2017

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9540350 - 1-substituted, 4-(substituted phenoxymethyl)-1,2,3-triazole compounds with antifungal properties and methods for preparation thereof (2017-01-10),

2. 9512087 - Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation (2016-12-06),

3. 9447082 - Optically active fluconazole analogues containing thiophenes as antifungal agents (2016-09-20),

4. 9181269 - Enantiomers of fluconazole analogues containing thieno-[2,-3-D]pyrimidin-4(3H)-one moiety as antifungal agents (2015-11-10),

5. 8324227 - [object Object] (2012-12-04),

6. 8236840 - Thiopene containing analogues of fluconazole as antifungal agents and process for their preparation (2012-08-07),

7. 8129369 - Antifungal compounds containing benzothiazinone, benzoxazinone or benzoxazolinone and process thereof (2012-03-06),

8. 7226939 - Thienopyridine analogues with antifungal activity and process thereof (2007-06-05),

Title: Mohan Anand Chandavarkar: Innovator in Antifungal Compounds

Introduction

Mohan Anand Chandavarkar is a notable inventor based in Mumbai, India. He has made significant contributions to the field of antifungal compounds, holding a total of 8 patents. His work focuses on developing novel compounds that can effectively combat fungal infections.

Latest Patents

Chandavarkar's latest patents include innovative compounds such as 1-substituted, 4-(substituted phenoxymethyl)-1,2,3-triazole compounds with antifungal properties. These compounds are designed to prevent and treat fungal infections through unique formulations that include triazole rings and phenyl rings. Another significant patent involves hybrid molecules containing fluconazole pharmacophores, which are coupled with other moieties like aryl enones and chalcones. These advancements represent a promising direction in antifungal treatment.

Career Highlights

Throughout his career, Mohan Anand Chandavarkar has worked with reputable organizations such as FDC Limited and the Council of Scientific & Industrial Research. His experience in these institutions has allowed him to refine his expertise in pharmaceutical innovations.

Collaborations

Chandavarkar has collaborated with notable colleagues, including Hanumant Bapurao Borate and Subhash Prataprao Chavan. These partnerships have contributed to the development of his groundbreaking research and patents.

Conclusion

Mohan Anand Chandavarkar's contributions to antifungal compounds highlight his innovative spirit and dedication to addressing critical health challenges. His patents and collaborations reflect a commitment to advancing pharmaceutical science.

Profile summary based on public USPTO records.